Retraction: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling

Editorial Office, Frontiers

doi:10.3389/fonc.2025.1591122

RETRACTION article

Front. Oncol.

Sec. Pharmacology of Anti-Cancer Drugs

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1591122

This article is part of the Research Topic Anticancer Potential of Artemisia Annua View all 9 articles

Retraction: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling

Provisionally accepted

Frontiers Editorial Office ^*

Frontiers Media SA, Lausanne, Switzerland

This article is a retraction of:

Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
1. Read original article

The final, formatted version of the article will be published soon.

Please find the retraction statement below:Yi Y-C, Liang R, Chen X-Y, Fan H-N, Chen M, Zhang J and Zhu J-S (2021) Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling. Front. Oncol. 11:768879. doi: 10.3389/fonc.2021.768879“Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers' policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors do not agree to this retraction.”

Keywords: Dihydroartemisinin, Cell Cycle, Cdk1, colorectal cancer, Growth, CCNB1

Received: 11 Mar 2025; Accepted: 11 Mar 2025.

Copyright: © 2025 Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.